This inventor holds 3 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kanagawa, JP (2016)
- Hiratsuka, JP (2015 - 2017)
Company Filing History:
Years Active: 2015-2017
Title: Koichi Ishidoh: Innovator in Pharmaceutical Composition
Introduction
Koichi Ishidoh is a notable inventor based in Hiratsuka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that enhance drug solubility across various pH levels. With a total of 3 patents to his name, Ishidoh's work is recognized for its innovative approach to pharmaceutical formulations.
Latest Patents
Ishidoh's latest patents include a pharmaceutical composition designed to provide satisfactory dissolution properties in a wide pH range. This composition is characterized by containing a specific compound, N-(5-chloropyridin-2-yl)-N-((1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-{[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}cyclohexyl)ethanediamide, along with a pharmacologically acceptable salt or hydrate. Another significant patent involves a pharmaceutical composition containing a diamine derivative, which aims to provide a compound that dissolves favorably in the neutral region.
Career Highlights
Koichi Ishidoh is currently associated with Daiichi Sankyo Company, Limited, where he continues to innovate in the pharmaceutical sector. His work focuses on improving drug formulations to enhance their effectiveness and patient compliance.
Collaborations
Ishidoh has collaborated with notable colleagues such as Masazumi Kojima and Yoshio Kuno, contributing to the advancement of pharmaceutical research and development.
Conclusion
Koichi Ishidoh's contributions to pharmaceutical compositions demonstrate his commitment to innovation in drug formulation. His patents reflect a deep understanding of the complexities involved in creating effective pharmaceutical preparations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
